A Phase 1, Open-label, Randomized, Single Dose, Crossover Study Evaluating The Pharmacokinetics Of Epoetin Following Administration Of Epoetin Hospira Multiple Dose Vial (MDV) Product Compared To Epoetin Hospira Single Dose Vial (SDV) Product As Subcutaneous Injection To Normal Healthy Subjects

Trial Profile

A Phase 1, Open-label, Randomized, Single Dose, Crossover Study Evaluating The Pharmacokinetics Of Epoetin Following Administration Of Epoetin Hospira Multiple Dose Vial (MDV) Product Compared To Epoetin Hospira Single Dose Vial (SDV) Product As Subcutaneous Injection To Normal Healthy Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Feb 2018

At a glance

  • Drugs Epoetin zeta (Primary)
  • Indications Anaemia
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Jan 2018 Planned primary completion date changed from 1 May 2018 to 11 May 2018.
    • 30 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 29 Jan 2018 Planned End Date changed from 1 May 2018 to 11 May 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top